Company rep reported post implantation of seri during a left side revision augmentation, pt presented on (b)(6) 2014 with left side cellulitis and inflammation causing "distortion of the breast, pushing the native breast up and in." physician reports the events as being considered device related.Seri device was explanted on (b)(6) 2014, and has been returned by the physician.
|
Allergan has received the product, however the analysis has not been completed at this time.The events of necrosis, cellulitis, irritation/inflammation, and visibility/palpability are surgical/physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.
|